NCT06969040 The Effect of Standard Cognitive-behavioral Therapy+Transcranial Alternating Current on Refractory Insomnia Disorder
| NCT ID | NCT06969040 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Insomnia |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-11-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main purpose of this study is to investigate the efficacy of CBTI + transcranial alternating current (TAC) technology in the treatment of refractory insomnia and the mechanism of 'cognitive-behavioural-brain network' interactions.
Eligibility Criteria
Inclusion Criteria: 1. Meets the diagnostic criteria for insomnia in DSM-5; 2. Pittsburgh Sleep Quality Index (PSQI) total score\>5 points; 3. Age ≥ 18 years old, with a junior high school education or above; 4. Voluntarily participate in this study and sign an informed consent form. Exclusion Criteria: 1. Individuals with severe physical or mental illnesses are at risk of suicide; 2. Clinically diagnosed or suspected sleep breathing disorders, restless leg syndrome, and sleep wake rhythm disorders, as well as workers on rotating shifts; 3. Pregnant and lactating women; 4. Currently undergoing any psychological therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06969040 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06969040 currently recruiting?
Yes, NCT06969040 is actively recruiting participants. Contact the research team at wanghongxing@xwh.ccmu.edu.cn for enrollment information.
Where is the NCT06969040 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06969040 clinical trial?
NCT06969040 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.